Atlas Trials

Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated in Patients With Previously Treated Metastatic Colorectal Cancer

Clinical trial NCT03880877 · UNKNOWN

Trial details

NCT number
NCT03880877
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2019-02-26
Primary completion
2021-03-01
Enrollment
153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.